AlphaStreet Newsdesk powered by AlphaStreet Intelligence
Daré Bioscience, Inc. (DARE) posted a Q1 2026 diluted lack of $0.20 per share, narrower than the -$0.30 anticipated loss (33.3% narrower). The corporate generated $152,455 in income for the quarter.
Daré Bioscience, Inc. is a Biotechnology firm. The corporate posted a internet lack of $3.0M for the quarter.
Wall Avenue consensus stands at 7 purchase, 1 maintain, 0 promote. Yr-over-year, the per-share loss narrowed to $0.20 from $0.50 in Q1 2025, a 60.0% enchancment. Income was up 499.6% from $25,427 in Q1 2025.
An in depth evaluation of Daré Bioscience, Inc.’s quarter follows shortly on AlphaStreet.
This content material is for informational functions solely and shouldn’t be thought of funding recommendation. AlphaStreet Intelligence analyzes monetary information utilizing AI to ship quick and correct market info. Human editors confirm content material.
